Latest News

UC Davis establishes alliance of excellence in biophotonics with German Leibniz Institute for Photonic Technologies

November 14, 2017
The University of California, Davis, and the Leibniz Institute for Photonic Technologies (Leibniz-IPHT), in Jena, Germany, have entered an agreement of cooperation to establish the Jena-Davis (JEDIS) Alliance of Excellence in Biophotonics — designed to promote North American-German cooperation on research and development in the field of biophotonics.

Engineering new cell-based strategies with microangiospheres

November 06, 2017
Pre-vascular microtissues delivered in a microhydrogel injection are better able to lay the groundwork necessary for blood vessels to grow. Cell-based strategies are seen as true game changers in the context of ischemic vascular diseases because they aim to cure and not simply to ameliorate these diseases.

Emilie Roncali receives pilot grant to improve liver cancer treatment

October 05, 2017
Emilie Roncali, an Assistant Project Scientist in the Cherry Lab, has received an Institutional Research Grant Pilot Funding from the UC Davis Comprehensive Cancer Center to investigate the effectiveness of combined radioemobolization therapy and PET imaging for liver cancer.

Jamal Lewis Receives Prestigious NIH MIRA Grant

August 31, 2017
Jamal Lewis has received a National Institutes of Health of Maximizing Investigators’ Research Award (MIRA) for New and Early Stage Investigators. The grant, which will support the Lewis lab’s work to understand and exploit the phenomenon of vomocytosis, is $1.9 million over the next five years.

Steven George Elected BMES Fellow

August 22, 2017
The Biomedical Engineering Society will welcome Steven George into its Class of 2017 Fellows in a ceremony at its annual meeting, held October 11-14 in Phoenix.

NIH funds project to model atrial fibrillation with heart-on-a-chip

August 08, 2017
George and his collaborators plan to create atrial tissue from a patient’s own stem cells, and induce changes in the cells using CRISPR technology (“gene editing”) to alter their protein expression so that they conduct electricity in a pattern resembling that seen in atrial fibrillation.

Paralyzed rats walk again after experimental treatment

August 03, 2017
Karen Moxon, a professor of biomedical and mechanical engineering at UC Davis, showed that a combined therapeutic regimen of drugs and physical therapy promoted cortical reorganization that bypassed a spinal cord injury, allowing paralyzed rats to walk again.